Citizen Health, an AI-based consumer health platform designed to support 400+ million individuals managing rare and complex conditions, announced the closing of a $14.5 million seed round. This funding round was led by Transformation Capital, with participation from Wavemaker 360 and prominent angel investors. This fundraising is further strengthened by a strategic program investment and partnership with the Chan Zuckerberg Initiative (CZI).
Addressing healthcare, especially for rare diseases, presents major challenges. With over 10,000 rare diseases and 95% lacking approved therapies, patients often struggle to find effective care pathways. And Citizen Health addresses this gap by building a comprehensive knowledge base that captures each patient’s complete health journey, such as clinical data, genetic information, imaging, and patient-reported outcomes.
This repository enables patients to access answers based on others’ experiences and assists researchers in accelerating drug development by providing immediate access to critical information, reducing the time to develop new therapies by years.
Citizen Health’s launch is supported by a strategic investment and collaboration with CZI’s Rare As One Project, which supports patient-led organizations working to accelerate research and improve the lives of people affected by rare diseases. And Citizen Health founders’ personal experiences navigating the healthcare system as patients and caregivers inspired them to partner with CZI. CZI’s support aims to help rare disease groups and scientists better understand rare diseases, accelerate the launch of clinical trials, and advance drug development.
Citizen Health plans to announce additional major partnerships and new product features in the coming months, benefiting patients and advancing its mission to transform the healthcare landscape for those with rare and complex conditions.
KEY QUOTES:
“With our collective experience and expertise, we’re working together to drive a future where any patient, at any stage, of any condition, has immediate access to exceptional guidance on the best action to take. Through our AI-powered platform, we are giving people agency over their health data to help themselves and each other, while shaving years off the drug development process for these critical diseases.”
-Farid Vij, CEO and co-founder of Citizen Health
“As precision medicine evolves, understanding patients at an individual level is crucial for developing tailored therapies and care options. This shift in empowering patients and caregivers is the path to a true consumer-led health system for every patient across every condition, and in no area is this more amplified than in rare and complex conditions.”
– Nasha Fitter, co-founder and chief business officer, who is inspired by her youngest daughter who suffers from an ultra-rare disease
“Rare diseases are not as rare as they seem, and empowering patients to direct their data to research opportunities can accelerate biomedical research for everyone. Citizen Health’s expertise in AI, healthcare, and commitment to patient centricity is opening new avenues for rare disease patients to drive research forward and advance the development of new treatments.”
– Tania Simoncelli, Vice President of Science in Society at the Chan Zuckerberg Initiative
